Shin splints are a common cause of leg pain in athletes. When an athlete has pain along the inner aspect of the shinbone, this can be due to shin splints. There are several medical conditions that can cause leg pain. Ranging from overuse in running, having arch problems, or exercising in shoes that are worn.
You can help prevent shin splints by wearing proper fitting athletic shoes, slowly increase your exercise routine, and cross training. For example you can alternate training from running to biking or swimming.
If you are having shin pain there are a few thing you can do to help alleviate the pain. Rest can be good. Ice your shins for 20 minutes at a time 2-3 times a day, take some type of NSAID medicine, compression, and orthotics can offer pain relief.
If these measures do not help and you are still having pain, an Orthopaedic evaluation can help establish a definitive diagnosis.
I am Jessillyn Howard, one of MOG’s athletic trainers. Driving down the road one day, I heard two radio hosts discuss a blood test that is able to identify a concussion. “That’s awesome!” I thought, “A test to identify concussion would eliminate any guess work and be proof to athletes, coaches, and parents when return to play is questioned.” My hopes, however, were crushed when I read the article published by NATA named “How to Address the New Blood Biomarker Test.”
In this article, the author disproves these claims made about this test. This biomarker can be used to detect intracranial hemorrhage, or bleeding between the brain and the skull, without use of a CT scan. This is helpful in limiting x-ray exposure to patients in which intracranial hemorrhage is suspected. This test, along with any other test or imaging, cannot diagnose concussion. The article states, “concussion remains a clinical diagnosis determined by the mechanism of injury, on-field signs and patient-reported symptoms.” This only solidifies the need for athletic trainers not only in schools, but anywhere sports-related concussion may be possible.
You can read NATA’s article “How to Address the New Blood Biomarker Test” HERE.